Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Mammogram, SARS-CoV-2 test, Ultrasound breast
Clinical narrative: COVID-19; hair loss; possible issue in her lungs; pain in her breast; her lymph nodes were super swollen/still very swollen; 1st dose of Moderna COVID-19 Vaccine on 20Aug2021 and 2nd dose on 10Sep2021; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID-19), BREAST PAIN (pain in her breast), ALOPECIA (hair loss), LUNG DISORDER (possible issue in her lungs) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose of Moderna COVID-19 Vaccine on 20Aug2021 and 2nd dose on 10Sep2021) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037F21A and 062E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient had no allergies. Patient had no history relating to mentioned adverse event and both Acute and Chronic illnesses at the time of vaccination. Patient had not received other vaccines within 1 month prior to Moderna COVID-19 vaccine.    On 20-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose of Moderna COVID-19 Vaccine on 20Aug2021 and 2nd dose on 10Sep2021). In November 2021, the patient experienced BREAST PAIN (pain in her breast) and LYMPHADENOPATHY (her lymph nodes were super swollen/still very swollen). On 14-Feb-2022, the patient experienced COVID-19 (COVID-19). In 2022, the patient experienced ALOPECIA (hair loss) and LUNG DISORDER (possible issue in her lungs). The patient was treated with VITAMIN E [VITAMIN E NOS] at a dose of 40 milligram. At the time of the report, COVID-19 (COVID-19) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose of Moderna COVID-19 Vaccine on 20Aug2021 and 2nd dose on 10Sep2021) outcome was unknown and BREAST PAIN (pain in her breast), ALOPECIA (hair loss), LUNG DISORDER (possible issue in her lungs) and LYMPHADENOPATHY (her lymph nodes were super swollen/still very swollen) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2021, Mammogram: lymph nodes were super swollen. In November 2021, Ultrasound breast: lymph nodes were super swollen. On 14-Feb-2022, SARS-CoV-2 test: Positive. In 2022, Mammogram: lymph nodes were still very swollen.         Patient was not under any regular or concomitant medication. Patient had not experienced a similar event in the past. The patient was also experiencing a possible issue in her lungs, but she would visit a specialist soon. Symptoms were still ongoing, recently another mammography showed that lymph nodes were still very swollen. Treatment given was Vitamin E 40 mg and she had to use a sport bra. Doctors tried to do a biopsy but it was not possible. Patient got COVID-19 but she had not felt bad and was isolated during 1 week. Patient visited gynecologist and breast oncologist.